Cargando…
c-MET as a Potential Therapeutic Target in Ovarian Clear Cell Carcinoma
In this study, we investigated the therapeutic effects of c-MET inhibition in ovarian clear cell carcinoma (OCCC). Expression levels of c-MET in the epithelial ovarian cancers (EOCs) and normal ovarian tissues were evaluated using real-time PCR. To test the effects of c-MET inhibitors in OCCC cell l...
Autores principales: | Kim, Ha-Jeong, Yoon, Aera, Ryu, Ji-Yoon, Cho, Young-Jae, Choi, Jung-Joo, Song, Sang Yong, Bang, Heejin, Lee, Ji Soo, Cho, William Chi, Choi, Chel Hun, Lee, Jeong-Won, Kim, Byoung-Gie, Bae, Duk-Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137074/ https://www.ncbi.nlm.nih.gov/pubmed/27917934 http://dx.doi.org/10.1038/srep38502 |
Ejemplares similares
-
Clinical outcomes of patients with clear cell and endometrioid ovarian cancer arising from endometriosis
por: Paik, E Sun, et al.
Publicado: (2018) -
A comparison of uterine papillary serous, clear cell carcinomas, and grade 3 endometrioid corpus cancers using 2009 FIGO staging system
por: Kim, Ha-Jeong, et al.
Publicado: (2013) -
Sphingosine kinase 1 is a reliable prognostic factor and a novel therapeutic target for uterine cervical cancer
por: Kim, Hyun-Soo, et al.
Publicado: (2015) -
Interval between secondary cytoreductive surgery and adjuvant chemotherapy is not associated with survivals in patients with recurrent ovarian cancer
por: Jeong, Soo Young, et al.
Publicado: (2019) -
Prognostic significance of normal-sized ovary in advanced serous epithelial ovarian cancer
por: Paik, E Sun, et al.
Publicado: (2018)